Cart
sales@molnova.com
Protopanaxatriol
CAS No. 1453-93-6
Protopanaxatriol( 20(R)-APPT )
Catalog No. M18030 CAS No. 1453-93-6
Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 80 | In Stock |
|
| 5MG | 64 | In Stock |
|
| 10MG | 104 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 300 | In Stock |
|
| 100MG | 449 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProtopanaxatriol
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.
-
DescriptionProtopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.
-
In Vitro20(R)-Protopanaxatriol is a natural aglycone of ginsenosides Re, Rf, Rg1, Rg2 and Rh.
-
In Vivo——
-
Synonyms20(R)-APPT
-
PathwayOthers
-
TargetOther Targets
-
RecptorPPARγ
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number1453-93-6
-
Formula Weight476.73
-
Molecular FormulaC30H32O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 32 mg/mL; 67.12 mM
-
SMILESC1C[C@@H](C([C@@H]2[C@H](C[C@]3([C@@]4(CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]12C)O)[C@@](C)(CCC=C(C)C)O)C)C)O)(C)C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang Y, et al. Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice. Sci Rep. 2014 Dec 9;4:7375.
molnova catalog
related products
-
Nystatin A3
Nystatin, which belongs to the polyene group of antimycotics, is frequently used as a topical agent in the treatment of oro-pharyngeal candidosis.
-
(R)-Monepantel
(R)-Monepantel ((R)-AAD1566) has potential anticancer activity but no nematicidal activity.
-
STC314
STC314 is an anti-infective agent that reverses organ damage caused by excessive immune response by neutralizing extracellular histones and neutrophil trapping networks, and can be used in the study of sepsis and acute respiratory distress syndrome (ARDS).
